Innovation, Partnership Necessary To Bring Vaccines To The Poor

Noting the WHO this week endorsed a new Chinese-produced Japanese encephalitis vaccine, Bill Gates, co-chair of the Bill & Melinda Gates Foundation writes in the organization’s “Impatient Optimists” blog, “[T]here’s a powerful story here about the tremendous progress the world is making to save and improve the lives of the world’s poorest.” He discusses the partnership between PATH and the China National Biotec Group (CNBG) that helped make the vaccine available to millions. “What’s especially exciting about the announcement is the opportunity it creates for China to become a leader in creating great vaccines for the world,” Gates writes, adding the announcement “serves as a reminder that there’s still more work to be done to protect the poorest against other neglected diseases.” He continues, “We need more innovative manufacturers like CNBG, creative partners like PATH, and more generous donors to join this cause” to “bring the world closer to the day when all children, no matter where they live, will have access to lifesaving vaccines” (10/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.